GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Expenditure | ₹9,948 Cr | ₹9,985 Cr | ₹8,860 Cr | ₹8,943 Cr | ₹8,280 Cr |
What is the latest Total Expenditure of GLENMARK PHARMACEUTICALS ?
Year | Total Expenditure |
---|---|
Mar2024 | ₹9,948 Cr |
Mar2023 | ₹9,985 Cr |
Mar2022 | ₹8,860 Cr |
Mar2021 | ₹8,943 Cr |
Mar2020 | ₹8,280 Cr |
How is Total Expenditure of GLENMARK PHARMACEUTICALS Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2024 | ₹9,948 Cr | -0.36 | |
Mar2023 | ₹9,985 Cr | 12.70 | |
Mar2022 | ₹8,860 Cr | -0.93 | |
Mar2021 | ₹8,943 Cr | 8.01 | |
Mar2020 | ₹8,280 Cr | - |
Compare Total Expenditure of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹60,351.3 Cr | -4% | 27.2% | 51.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,712.0 Cr | -1.2% | 1.3% | 5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,623.0 Cr | -2% | 1.3% | 45.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,285.0 Cr | 1.4% | 11.9% | 15.7% | Stock Analytics | |
CIPLA | ₹119,010.0 Cr | -0.6% | -2% | -1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,118.0 Cr | -1.2% | -6.7% | -8.4% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -4% |
27.2% |
51.1% |
SENSEX | 0.1% |
1% |
2.6% |
You may also like the below Video Courses